| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Michael Gray | CFO and COO | Oct 10, 2024 | |||
| Erez Chimovits | Director, 10%+ Owner | Oct 15, 2024 | |||
| Everett Rand Sutherland | Chief Executive Officer, Director | Oct 10, 2024 | |||
| Ronald C. Renaud JR | Director | Oct 10, 2024 | |||
| Orbimed Advisors Llc | Director, 10%+ Owner | Oct 15, 2024 | |||
| Harold Edward Fleming | Director | Oct 10, 2024 | |||
| Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | 10%+ Owner | Oct 15, 2024 | |||
| Aaron Deykin | Chief Medical Officer | Oct 10, 2024 | |||
| Liam Ratcliffe | Director | Oct 10, 2024 | |||
| Marcella K. Ruddy | Director | Oct 10, 2024 | |||
| Adam Houghton | Chief Business Officer | Oct 10, 2024 | |||
| AI Upstream LLC | 10%+ Owner | Oct 15, 2024 | |||
| Daniella Beckman | Director | Oct 10, 2024 | |||
| Allison Ambrose | General Counsel | Dec 16, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|